Ausgabe 2/2001
Inhalt (9 Artikel)
Biomarker prediction of clinical outcome in operable breast cancer patients treated with tamoxifen
Emanuela Scarpi, Franca De Paola, Manuela Sarti, Paola Bajorko, Anna Maria Granato, Annalisa Volpi, Oriana Nanni, Roberta Maltoni, Dino Amadori
Immunohistochemical analysis of prostate specific antigen in breast cancer*
Michael K. Miller, Pamela D. Unger, Ira J. Bleiweiss
Rural-urban differences in radiation therapy for ductal carcinoma in-situ of the breast
Mario Schootman, Rebecca Aft
Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780
K. B. Lim, C. Y. Ng, C. K. Ong, C. S. Ong, E. Tran, T. T. T. Nguyen, G. M. T. W. Chan, H. Huynh
Effect of α-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture
Andrea Manni, Daniel Trout, Michael F. Verderame, Sharlene Washington, David Mauger, Laurence Demers
Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome
Vahit Ozmen, Neslihan Cabioglu, Kemal Dolay, Ayhan Bilir, Mustafa Kecer, Adnan Aydiner, Mahmut Muslumanoglu, Abdullah Igci, Yavuz Bozfakioglu, Temel Dagoglu
Premorbid body weight and its relations to primary tumour diameter in breast cancer patients; its dependence on estrogen and progesteron receptor status
Bjørn Ove Mæhle, Steinar Tretli, Rolv Skjærven, Thor Thorsen
Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study*
Pier Franco Conte, Alessandra Gennari, Sara Donati, Barbara Salvadori, Editta Baldini, Carmelo Bengala, Ilaria Pazzagli, Cinzia Orlandini, Romano Danesi, Stefano Fogli, Mario Del Tacca